# To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids

> **NCT00053560** · PHASE3 · UNKNOWN · sponsor: **Genelabs Technologies** · enrollment: 155 (—)

## Conditions studied

- Lupus

## Interventions

- **DRUG:** Prasterone (GL701)

## Key facts

- **NCT ID:** NCT00053560
- **Lead sponsor:** Genelabs Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-12
- **Primary completion:** —
- **Final completion:** 2004-08
- **Target enrollment:** 155 (—)
- **Last updated:** 2008-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00053560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00053560, "To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00053560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*